Seven US Supreme Court justices issued their latest patent ruling yesterday in a case that may not have been awaited with the same level of expectancy as next month’s oral arguments in the venue selection case TC Heartland, but which nonetheless showed them sticking to form. As ever with this court it was a case of what wasn’t said as much as what was outlined in the decision.
Foreign patent owners face big hurdles when seeking to get damage awards and licence fees out of China
IAM readers are probably aware that the Chinese government began taking major steps to stem the outflow of capital from the country last year as its foreign currency reserves fell near the $3 trillion mark and the yuan weakened significantly against the dollar. The measures may be working, as the amount of yuan leaving China has slowed significantly. But they’ve also had some unintended...
The gene-editing tool CRISPR is in the process of transforming the life sciences industry. Perhaps not surprisingly with such a revolutionary technology still in its relative infancy, a dispute over patents between universities and research institutes that have been at the forefront of its development, erupted over just who owns some of the foundational IP. Last week in a closely watched...
It is all very well having an IP strategy – but ensuring it has a real commercial impact is another matter. There are, though, steps you can take to ensure that you are doing the best possible job
IAM Patent 1000
The definitive guide to leading patent lawyers, attorneys and firms in over 40 jurisdictions, with a special section on expert witnesses in the United States.Visit site